Stereotactic radiation therapy in non–small cell lung cancer (NSCLC) patients with operable Stage I disease resulted in a 76% overall survival at three years. These findings were recently presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).[1]

Lung cancer is a major cause of death worldwide, with over one million deaths per year. Non–small cell lung cancer (NSCLC) is the most common type of lung cancer. Early-stage NSCLC is most often treated with surgical resection with or without the addition of radiation therapy and/or chemotherapy. In some cases, patients may not be able to undergo surgery to remove their cancer due to underlying conditions such as emphysema or heart disease. Treatment of early-stage NSCLC patients who are unable to undergo surgery may include radiation therapy or observation. Strategies to improve treatment for this group of patients include stereotactic radiation therapy.

Stereotactic radiation therapy involves the very precise delivery of a large dose of radiation to a tumor while sparing normal tissue. Results from a study recently published in the Journal of the American Medical Association indicate that patients with early-stage NSCLC who were medically unable to undergo surgery to remove their cancer had a 55.8% overall survival at three years following stereotactic body radiation therapy.[2] Researchers recently conducted a study to evaluate whether or not early-stage NSCLC patients eligible for surgery might also benefit from stereotactic radiation therapy.

In this Phase II Japanese study, researchers evaluated stereotactic radiation therapy among 65 patients with Stage I NSCLC that was considered operable. At three years, overall survival was 76% and progression-free survival was 54.5%. Side effects tended to be mild.

The researchers concluded that stereotactic radiation therapy is effective with few side effects and may provide Stage I NSCLC patients with an alternative to surgery, especially elderly patients.

Reference:


[1] Nagata Y, Hiraoka M, Shibata T, et al. A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer. Japan Clinical Oncology Group (JCOG0403). Presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). November  , San Diego, CA. [Abstract 59].

[2] Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076.

Copyright © 2016 CancerConsultants. All Rights Reserved.

[ which is better viagra or cialis | where to purchase viagra | homemade viagra | viagra on line canadian pharmacy | viagra price | cialis brand | buy viagra without a prescription | sildenafil citrate voltammetry | viagra young men | female version viagra | low cost viagra | cialis express delivery | cialis dose | who invented viagra | viagra in india | brand viagra over the net | viagra deaths | viagra free trial | get viagra | when did viagra come out | cialis kanada | buying viagra online cheap us | cialis alternative | viagra in spain | cheap pill viagra | viagra for cheap | cheapest viagra in the world | viagra discount codes | viagra cartoon | viagra online without a prescription | herbal prescription viagra | cialis soft | cheap viagra | canada viagra | viagra picture | when do i take viagra | cialis en mexico | buy generic cialis expressdelivery | directions for viagra use | cialis once daily | viagra london | how strong is 5 mg of cialis | uk pharmacies cheap viagra | viagra no prescription | sildenafil citrate voltammetry | pfizer viagra 50 mg online | order cheap viagra | over the counter viagra | buying cialis | viagra cialis | getting viagra | viagra cheap prescription | women who take viagra | mexican viagra ]